In high-risk patients without prior heart attack or stroke who underwent percutaneous coronary intervention, evolocumab ...

Cholesterol bloodstream The multicenter, double-blind, placebo-controlled HAUSER-RCT study assessed the efficacy and safety of evolocumab in 157 patients aged 10 to 17 years with HeFH. Positive ...

The approval of Repatha was also expanded to include patients 10 years of age and older with HoFH. The Food and Drug Administration (FDA) has approved Repatha (evolocumab) injection as an adjunct to ...

Both Repatha and Praluent are used to treat high cholesterol and reduce the risk of certain cardiovascular events. The drugs also have different approved uses in adults and children. Repatha and ...

The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...

Richard Mullvain, RPh, BCPS (AQC), CCCC, a cardiovascular clinical pharmacist and expert in cardiovascular care at the Essentia Health Heart & Vascular Center in Duluth, Minnesota, delivered a focused ...

Discover comprehensive details about Evolocumab, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Most stand-alone Medicare Part D prescription drug plans and Medicare Advantage plans that include drug coverage cover Repatha, an injectable medication for high cholesterol and cardiovascular disease ...

GAITHERSBURG, MD (UPDATED June 11, 2015) — In the second US Food and Drug Administration (FDA) advisory meeting this week, the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) gave its ...

Evolocumab's indication now includes adults at risk of cardiovascular events due to uncontrolled LDL-C, even without a formal diagnosis. The therapy is approved for use in patients with high LDL-C ...

Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it ...